http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201821070-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fcbf0ceec413970d39781c0a93c5e5c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate | 2017-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_706a5df3082407966a4639b5483dab90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5d71308f83a5170a7428e4938b14897 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4888bd2546986c44f804b29651378a5d |
| publicationDate | 2018-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201821070-A |
| titleOfInvention | Tomoxetine hydrochloride oral solution and method thereof |
| abstract | The invention discloses an oral pharmaceutical composition which uses aqueous solution of tomoxetine as its active ingredient. Tomoxetine in aqueous solution contains a taste-masking liquid carrier, and it contains mint, orange flavor, and thickener. The aforementioned comprehensive flavor effectively masks the bitter odor and / or taste of tomoxetine hydrochloride, making it a novel and delicious pharmaceutical composition. The thickener enhances the consistency of the oral pharmaceutical composition and provides a smooth mouthfeel to make it easy to swallow. More specifically, the oral pharmaceutical composition comprises an effective amount of: (a) tomoxetine or a pharmaceutically acceptable salt thereof; and (b) a taste-masking liquid carrier. The present invention also provides a method for manufacturing the water-soluble tomoxetine. Furthermore, the present invention also provides a method for treating a subject with a treatable condition using the oral pharmaceutical composition, and the method is mainly oral tomoxetine. According to an embodiment of the present invention, the disorder is concentration disorder and hyperactivity (ADHD). |
| priorityDate | 2016-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 113.